| The Effects of Glucose/Ischemic Preconditioning on Reperfusion Injury in Deceased-Donor Liver Transplantation (NCT00718575) | University Health Network, Toronto | 2008-08-01 |
| FGL2/Fibroleukin and Hepatitis C Virus Recurrence Post Liver Transplantation (NCT00701272) | University Health Network, Toronto | 2008-06-01 |
| A Study of CellCept (Mycophenolate Mofetil) Combined With Calcineurin Inhibitors in Liver Transplant Patients. (NCT00717314) | Hoffmann-La Roche | 2008-05-01 |
| Effect of Immunosuppression Drug Weaning on Hepatitis C Virus (HCV)-Induced Liver Damage After Liver Transplantation (NCT00668369) | Hospital Clinic of Barcelona | 2008-04-01 |
| Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With Entecavir (NCT01046799) | HepNet Study House, German Liverfoundation | 2008-03-01 |
| Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients (NCT00722332) | Cangene Corporation | 2008-02-01 |
| Duct-to-duct vs Roux-en-y Hepaticojejunostomy for Biliary Reconstruction in Adult Living Donor Liver Transplantation (NCT00646685) | University Health Network, Toronto | 2008-02-01 |
| Preoperative Statin Use and Major Adverse Cardiovascular Events in Liver Transplant Recipients (NCT07089589) | Asan Medical Center | 2008-01-02 |
| A Study to Evaluate and Compare the Efficacy and Safety of FK506MR vs Prograf® in Stable Liver Transplantation Patients (NCT00619398) | Astellas Pharma Inc | 2008-01-01 |
| Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients (NCT00622869) | Novartis Pharmaceuticals | 2008-01-01 |
| A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients. (NCT00720408) | Astellas Pharma Inc | 2007-12-01 |
| A Study of Thymoglobulin and Tacrolimus in Liver Transplant (NCT00564538) | University of Nebraska | 2007-12-01 |
| Study of Resistance Strengthening Versus Ambulation Post-Liver Transplant (NCT01216722) | University of Miami | 2007-10-01 |
| Effects of Donor and Recipient Genetic Expression on Heart, Lung, Liver, or Kidney Transplant Survival (NCT00531921) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-09-01 |
| Hemodynamic Measurements During Liver Transplantation (NCT00682110) | Washington University School of Medicine | 2007-07-01 |
| Closed-loop Anesthesia, Using Bispectral Index as the Control Variable, During Liver Transplantation (NCT00477347) | Hopital Foch | 2007-05-01 |
| A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Liver Transplantation (NCT00459719) | Astellas Pharma Inc | 2007-03-01 |
| Measurement of Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Liver Transplant Recipients (NCT00405652) | Novartis Pharmaceuticals | 2007-01-01 |
| A Multicenter Study Evaluating the Safety and Tolerability of Intravenous rhMBL in Liver Transplant Recipients. (NCT00415311) | Enzon Pharmaceuticals, Inc. | 2006-12-01 |
| Prospective Evaluation of Predictors for Organ Failure Following Liver Transplantation (NCT00408889) | Heidelberg University | 2006-12-01 |
| Comparison of Quantiferon-TB Gold Assay With Tuberculin Skin Testing in Patients With Chronic Liver Disease (NCT00402402) | University Health Network, Toronto | 2006-10-01 |
| Reduction in the Risk of Rejection by Mycophenolate Mofetil Dose Adjustment in Liver Transplant Patients With Side Effects Caused by the Calcineurine Inhibitors (NCT00456235) | University Hospital, Limoges | 2006-09-01 |
| Cytokine Kinetics Test to Assess the Presence or Absence of Tolerance in Organ Transplant (NCT00585858) | University of Wisconsin, Madison | 2006-09-01 |
| Evaluation of Kidney Disease in Liver Transplant Recipients (NCT00585429) | University of Wisconsin, Madison | 2006-09-01 |
| Prophylactic Therapy for Cytomegalovirus in Liver Transplant Recipients (NCT00364052) | Oregon Health and Science University | 2006-08-01 |
| Preservation of Renal Function in Liver Transplant Recipients With Certican Therapy (NCT00378014) | Novartis Pharmaceuticals | 2006-08-01 |
| rATG Induction and Tacrolimus Monotherapy in Pediatric Liver Transplantation (NCT01207141) | University of Pittsburgh | 2006-08-01 |
| Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients (NCT00320606) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-05 |
| Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590AM3)(COMPLETED) (NCT00378599) | Merck Sharp & Dohme LLC | 2006-05-01 |
| A Study to Evaluate the Efficiency of Intravenously Administered Cyclosporine in de Novo Liver Transplant Recipients (NCT00332462) | Novartis Pharmaceuticals | 2006-05-01 |
| Endoscopic Evaluation in Transplantation Candidates (NCT00990470) | Hannover Medical School | 2006-02-01 |
| A Study to Assess the Safety and Efficacy of Prograf and MR4 in Liver Transplant Recipients (NCT00719745) | Astellas Pharma Inc | 2006-02-01 |
| Assessment Of the Safety and Benefit of Prospective Immunosuppressive Drug Withdrawal in Liver Transplantation and Prediction of Operational Tolerance (NCT00647283) | Hospital Clinic of Barcelona | 2005-11-01 |
| RESCUE Study - Everolimus in Liver Transplantation Recipients With Renal Insufficiency (NCT00267189) | Novartis Pharmaceuticals | 2005-11-01 |
| Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation (NCT00297830) | Columbia University | 2005-11-01 |
| Ambisome in Liver Transplant Patients (NCT00161356) | The University of Texas Health Science Center, Houston | 2005-09-01 |
| Enteric Coated Myfortic for Liver Transplant Recipients (NCT00167492) | The University of Texas Health Science Center, Houston | 2005-09-01 |
| Immunogenicity of Booster Hepatitis B Vaccines in Children After Liver Transplantation (NCT00147459) | National Taiwan University Hospital | 2005-09-01 |
| Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant (NCT00118742) | Hoffmann-La Roche | 2005-08-01 |
| Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients (NCT00105235) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-06-01 |
| Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients (NCT00295607) | Astellas Pharma Inc | 2005-06-01 |
| Effects of Ursodeoxycholic Acid on Graft Recovery Early After Adult Liver Transplantation (NCT01073202) | Shanghai Jiao Tong University School of Medicine | 2005-05-01 |
| Quality of Life in Pediatric Transplant Recipients (NCT00209196) | Emory University | 2005-05-01 |
| Benefit of Immunoprophylaxis on Fibrosis to Reduce Viral Load After Liver Transplantation (NCT00538265) | University Hospital, Toulouse | 2005-05-01 |
| Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-optimal Grafts (NCT00321074) | Astellas Pharma Inc | 2005-05-01 |
| Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation. (NCT00295594) | Astellas Pharma Inc | 2005-03-01 |
| Liver Transplantation Results in Hepatocellular Carcinoma Patients With Immunosuppression Without Steroids (NCT01137084) | Shanghai Jiao Tong University School of Medicine | 2005-01-01 |
| MMF After Pediatric Liver Transplantation (NCT00367146) | Hannover Medical School | 2004-11-01 |
| Conversion Trial From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS) in Stable Transplanted Patients Suffering From Gastrointestinal (GI) Adverse Events While on Mycophenolate Mofetil Therapy (MMF) Therapy (NCT00149942) | Novartis | 2004-10-01 |
| A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Liver Transplantation. (NCT00189826) | Astellas Pharma Inc | 2004-08-01 |
| Study of Sequential Perfusion of Liver Grafts to Prevent Nonanastomotic Biliary Strictures After Liver Transplantation (NCT01271179) | Shanghai Jiao Tong University School of Medicine | 2004-07-01 |
| Vasosol Organ Perfusion Solution and Medtronic Portable Bypass System (NCT00879268) | Polyak, Maximilian | 2004-07-01 |
| Long-term Follow-up of Living Liver Donors: A Single-center Experience (NCT04814290) | Mansoura University | 2004-05-01 |
| Efficacy and Safety of Basiliximab, Cyclosporine/Cyclosporine Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients Avoiding Intraoperative Steroids (NCT00149890) | Novartis | 2004-03-01 |
| A Study of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Pediatric Liver Transplant Patients (NCT00282256) | Astellas Pharma Inc | 2004-01-01 |
| Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation (NCT00080236) | Conatus Pharmaceuticals Inc. | 2003-11-01 |
| Prophylaxis With Caspofungin in High-Risk Liver Transplantation (NCT00333645) | Grupo de Estudio de Infecciones en Transplantados | 2003-10-01 |
| Study to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long Term and in Combination With Other Immunosuppressive Drugs in Patients Who Have Received a Transplant (NCT02118896) | Astellas Pharma Europe Ltd. | 2003-02-24 |
| A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant Patients (NCT00282243) | Astellas Pharma Inc | 2003-02-01 |
| Validation of the TRAIN-AI for the Risk of HCC Recurrence After Liver Transplantation (NCT06799468) | European Hepatocellular Cancer Liver Transplant Group | 2003-01-01 |
| Study Evaluating of Calcineurin Inhibitor and Sirolimus (Rapamune) Treatment in Liver Transplant Recipients (NCT00086346) | Wyeth is now a wholly owned subsidiary of Pfizer | 2002-12-01 |
| Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TX (NCT00693524) | Astellas Pharma Inc | 2002-11-01 |
| A Study to Evaluate the Safety and Effectiveness of FK778 in Liver Transplant Patients (NCT00451932) | Astellas Pharma Inc | 2002-10-01 |
| Single Center Pilot Study of Corticosteroid Discontinuation in Liver Transplant Recipients (NCT00374231) | University of Cincinnati | 2002-10-01 |
| MMF Influence on HCV Viral Evolution After Liver Transplantation (NCT00170131) | Mayo Clinic | 2002-09-01 |
| Comparison of Immunosuppression Protocols After LTx in Children (NCT00195988) | Children's Memorial Health Institute, Poland | 2002-09-01 |
| An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in "de Novo" Liver Transplantation. (NCT00343226) | Novartis | 2002-05-01 |
| Use of Bisphosphonates in the Treatment of Osteopathy After Liver Transplantation (NCT00302484) | Medical University of Vienna | 2002-04-01 |
| Evaluation of Celsior® in Liver Transplant Preservation. (NCT00151593) | Rennes University Hospital | 2002-02-01 |
| Effectiveness of Raltegravir-Based Antiretroviral Therapy in HIV-HCV Coinfected Liver Transplant Recipients (NCT02995824) | Hospital Clinic of Barcelona | 2002-01-01 |
| Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular Carcinoma (NCT00300521) | Beijing Chao Yang Hospital | 2000-09-01 |
| The Effect of Zoledronic Acid on Bone Density in Liver Transplant Patients (NCT00114556) | Royal Prince Alfred Hospital, Sydney, Australia | 2000-02-01 |
| HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection (NCT00228592) | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| Osteoporosis in Children and Adults Following Liver Transplantation (NCT00008788) | National Center for Research Resources (NCRR) | |